Skip to content

Investigating the effect of family-centered intervention on adherence to diabetes treatment

Design, implementation and evaluation of family-centered intervention program on adherence to treatment in Type 2 Diabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220907055909N1
Enrollment
110
Registered
2022-10-03
Start date
2026-02-27
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus without complications

Interventions

Intervention 1: Intervention group: This group will receive the intervention under the application on the mobile phone for 8 weeks, and all educational programs will be presented to the intervention g

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Have type 2 diabetes and their diabetes has been diagnosed and confirmed by a doctor before registration Have diabetes for at least 6 months HbA1c level equal to or greater than 7 Be in the age range of 18 to 60 years old Be literate in reading and writing Have a phone at home Have a mobile phone personally or in the family in order to participate in the program Do not have disabling physical problems and diseases Are not pregnant and do not intend to become pregnant during the study period Do not suffer from known psychological diseases Do not suffer from serious diseases (such as liver failure, kidney failure, etc.) Willing to participate in the study and complete the informed consent form Do not currently participate in other research studies. Family member entry criteria: Be over 18 years old Do not have diabetes Be a First degree family member (wife, child, parent, sister or brother) Be literate in reading and writing Willing to participate in the study Can use a smartphone

Exclusion criteria

Exclusion criteria: Being hospitalized during the study for any reason Suffering from diabetic ketoacidosis or hyperglycemic hyperosmolar Nonketotic syndrome Suffering from serious diseases such as advanced form of cardiovascular diseases, uncontrolled high blood pressure, psychological disorders, severe vision disorders, psychiatry diseases or suffering from physical or mental problems preventing participation in the research Unwillingness of the patient or family member to participate or continue cooperation

Design outcomes

Primary

MeasureTime frame
Medication compliance score. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Morisky Medication Adherence Scale.;Physical activity score. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: International Physical Activity Questionnaire (IPAQ ).;Self-Efficacy Scale. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Diabetes Management Self-Efficacy Scale(DMSES).;Self-care behaviors score. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Summary of Diabetes Self Care Activities (SDSCA).;Perceived family social support score. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Diabetes Specific Family Support Scale.;Self-regulation score in treatment. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Treatment Self-Regulation Questionnaire (TSRQ).

Secondary

MeasureTime frame
Glycosylated hemoglobin. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Blood sample test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Azemat Mousavifar

Esfahan University of Medical Sciences

mousavifar.a@mui.ac.ir+98 31 3668 8628

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026